Maximiliano L. Cacicedo

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations.

Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations.

Journal: International journal of biological macromolecules

Published: May 26, 2025

mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models.

mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 30, 2025

Encapsulation of Dexamethasone into mRNA-Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies.

Encapsulation of Dexamethasone into mRNA-Lipid Nanoparticles Is a Promising Approach for the Development of Liver-Targeted Anti-Inflammatory Therapies.

Journal: International journal of molecular sciences

Published: September 23, 2024

mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance.

mRNA-LNP vaccine strategies: Effects of adjuvants on non-parenchymal liver cells and tolerance.

Journal: Molecular therapy. Methods & clinical development

Published: August 15, 2024

Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy.

Optimizing mRNA-Loaded Lipid Nanoparticles as a Potential Tool for Protein-Replacement Therapy.

Journal: Pharmaceutics

Published: May 15, 2024

Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications.

Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications.

Journal: International journal of molecular sciences

Published: May 05, 2023

mRNA-Based Approaches to Treating Liver Diseases.

mRNA-Based Approaches to Treating Liver Diseases.

Journal: Cells

Published: September 05, 2022

Colloidal delivery of vitamin E into solid lipid nanoparticles as a potential complement for the adverse effects of anemia treatment.

Colloidal delivery of vitamin E into solid lipid nanoparticles as a potential complement for the adverse effects of anemia treatment.

Journal: Chemistry and physics of lipids

Published: August 03, 2022

Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.

Modification of Regulatory T Cell Epitopes Promotes Effector T Cell Responses to Aspartyl/Asparaginyl β-Hydroxylase.

Journal: International journal of molecular sciences

Published: July 30, 2022

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice.

Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice.

Journal: Frontiers in bioengineering and biotechnology

Published: July 13, 2022

Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells.

Nanostructured Lipid Carriers Loaded with Dexamethasone Prevent Inflammatory Responses in Primary Non-Parenchymal Liver Cells.

Journal: Pharmaceutics

Published: July 01, 2022

OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells.

OVA-PEG-R848 nanocapsules stimulate neonatal conventional and plasmacytoid dendritic cells.

Journal: Frontiers in pediatrics

Published: June 10, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026